Clinical Trial Update: Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC [Phase 2]

View source ↗

Summary

Phase II study evaluating itraconazole in combination with pemetrexed in patients with previously treated non-squamous non-small cell lung cancer; the trial was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Itraconazole (Itraconazole)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Recurrent Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-02-01